The sonic hedgehog-induced type 3 deiodinase facilitates tumorigenesis of basal cell carcinoma by reducing Gli2 inactivation

Endocrinology

Volumn 155, Issue 6, 2014, Pages 2077-2088

  Luongo, Cristina ^a   Ambrosio, Raffaele ^b   Salzano, Salvatore ^c   Dlugosz, Andrzej A ^d   Missero, Caterina ^e   Dentice, Monica ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Istituto di Ricovero e Cura a Carattere Scientifico Fondazione Studio di Diagnostica Nucleare   (Italy)

^c CNR   (Italy)

^d UNIVERSITY OF MICHIGAN   (United States)

^e Naples Oncogenomic Center Centro d'Ingegneria Genetica Biotecnologie Avanzate   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; SONIC HEDGEHOG PROTEIN; THYROXINE DEIODINASE; TRANSCRIPTION FACTOR GLI2; IODIDE PEROXIDASE; IODOTHYRONINE DEIODINASE TYPE III; KRUPPEL LIKE FACTOR; LIOTHYRONINE; THYROID HORMONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BASAL CELL CARCINOMA; CARCINOGENESIS; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME INDUCTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ANIMAL; CELL LINE; CELL TRANSFORMATION; ENZYMOLOGY; FLOW CYTOMETRY; GENETICS; METABOLISM; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, BASAL CELL; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; FLOW CYTOMETRY; HUMANS; IODIDE PEROXIDASE; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MICE; MICE, TRANSGENIC; REAL-TIME POLYMERASE CHAIN REACTION; THYROID HORMONES; TRIIODOTHYRONINE;

EID: 84901474172     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2013-2108     Document Type: Article

References (52)

1. Oppenheimer JH, Schwartz HL, Mariash CN, Kinlaw WB, Wong NC, Freake HC. Advances in our understanding of thyroid hormone action at the cellular level. Endocr Rev. 1987;8: 288-308.
2. Yen PM, Ando S, Feng X, Liu Y, Maruvada P, Xia X. Thyroid hormone action at the cellular, genomic and target gene levels. Mol Cell Endocrinol. 2006; 246: 121-127.
3. Gereben B, Zavacki AM, Ribich S, et al. Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling. Endocr Rev. 2008;29: 898-938.
4. Wu Y, Koenig RJ. Gene regulation by thyroid hormone. Trends Endocrinol Metab. 2000;11: 207-211.
5. Dentice M, Marsili A, Zavacki A, Larsen PR, Salvatore D. The deiodinases and the control of intracellular thyroid hormone signaling during cellular differentiation. Biochim Biophys Acta. 2013;1830: 3937-3945.
6. Ambrosio R, Damiano V, Sibilio A, et al. Epigenetic control of type 2 and 3 deiodinases in myogenesis: role of lysine-specific demethylase enzyme and FoxO3. Nucleic Acids Res. 2013;41: 3551-3562.
7. Huang SA, Tu HM, Harney JW, et al. Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas. N Engl J Med. 2000; 343: 185-189.
8. Kester MH, Kuiper GG, Versteeg R, Visser TJ. Regulation of type III iodothyronine deiodinase expression in human cell lines. Endocrinology. 2006; 147: 5845-5854.
9. Dentice M, Ambrosio R, Salvatore D. Role of type 3 deiodinase in cancer. Expert Opin Ther Targets. 2009;13: 1363-1373.
10. Dentice M, Luongo C, Ambrosio R, et al.β-Catenin regulates deiodinase levels and thyroid hormone signaling in colon cancer cells. Gastroenterology. 2012; 143: 1037-1047.
11. Ingham PW, McMahon AP. Hedgehog signaling in animal development: paradigms and principles. Genes Dev. 2001;15: 3059-3087.
12. Ruiz i Altaba A, Sánchez P, Dahmane N. Gli and hedgehog in cancer: tumours, embryos and stem cells. Nat Rev Cancer. 2002;2: 361-372.
13. Jensen AM, Wallace VA. Expression of Sonic hedgehog and its putative role as a precursor cell mitogen in the developing mouse retina. Development. 1997;124: 363-371.
14. Goodrich LV, Milenkovic L, Higgins KM, Scott MP. Altered neural cell fates and medulloblastoma in mouse patched mutants. Science. 1997;277: 1109-1113.
15. Taipale J, Beachy PA. The Hedgehog and Wnt signalling pathways in cancer. Nature. 2001;411: 349-354.
16. Johnson RL, Rothman AL, Xie J, et al. Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science. 1996;272: 1668-1671.
17. Hahn H, Wicking C, Zaphiropoulous PG, et al. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell. 1996;85: 841-851.
18. Nilsson M, Undèn AB, Krause D, et al. Induction of basal cell carcinomas and trichoepitheliomas in mice overexpressing GLI-1. Proc Natl Acad Sci USA. 2000;97: 3438-3443.
19. Grachtchouk M, Mo R, Yu S, et al. Basal cell carcinomas in mice overexpressing Gli2 in skin. Nat Genet. 2000;24: 216-217.
20. Dentice M, Luongo C, Huang S, et al. Sonic hedgehog-induced type 3 deiodinase blocks thyroid hormone action enhancing proliferation of normal and malignant keratinocytes. Proc Natl Acad Sci USA. 2007;104: 14466-14471.
21. DenticeM.Hedgehog-mediated regulation of thyroid hormone action through iodothyronine deiodinases. Expert Opin Ther Targets. 2011;15: 493-504.
22. Huntzicker EG, Estay IS, Zhen H, Lokteva LA, Jackson PK, Oro AE. Dual degradation signals control Gli protein stability and tumor formation. Genes Dev. 2006;20: 276-281.
23. Pan Y, Bai CB, Joyner AL, Wang B. Sonic hedgehog signaling regulates Gli2 transcriptional activity by suppressing its processing and degradation. Mol Cell Biol. 2006;26: 3365-3377.
24. Sheng T, Chi S, Zhang X, Xie J. Regulation of Gli1 localization by the cAMP/ protein kinase A signaling axis through a site near the nuclear localization signal. J Biol Chem. 2006;281: 9-12.
25. Sheng H, Goich S, Wang A, et al. Dissecting the oncogenic potential of Gli2: deletion of an NH(2)-terminal fragment alters skin tumor phenotype. Cancer Res. 2002;62: 5308-5316.
26. Sasaki H, Nishizaki Y, Hui C, Nakafuku M, Kondoh H. Regulation of Gli2 and Gli3 activities by an amino-terminal repression domain: implication of Gli2 and Gli3 as primary mediators of Shh signaling. Development. 1999;126: 3915-3924.
27. Dentice M, Bandyopadhyay A, Gereben B, et al. The Hedgehog-inducible ubiquitin ligase subunit WSB-1 modulates thyroid hormone activation and PTHrP secretion in the developing growth plate. Nat Cell Biol. 2005;7: 698-705.
28. Narayanan CH, Narayanan Y, Browne RC. Development of the spinal tract of the trigeminal nerve and its relation to early fetal behavior in rats under normal and hypothyroid conditions. Exp Brain Res. 1986;62: 61-76.
29. Mihara S, Suzuki N, Wakisaka S, et al. Effects of thyroid hormones on apoptotic cell death ofhumanlymphocytes. J Clin Endocrinol Metab. 1999;84: 1378-1385.
30. HaraM, Suzuki S, Mori J, et al. Thyroid hormone regulation of apoptosis induced by retinoic acid in promyeloleukemic HL-60 cells: studies with retinoic acid receptor-specific and retinoid x receptor-specific ligands. Thyroid. 2000;10: 1023-1034.
31. HutchinME, KariapperMS, GrachtchoukM, et al. SustainedHedgehogsignaling is required for basal cell carcinoma proliferation and survival: conditional skin tumorigenesis recapitulates the hair growth cycle. Genes Dev. 2005;19: 214-223.
32. Regl G, Kasper M, Schnidar H, et al. The zinc-finger transcription factor GLI2 antagonizes contact inhibition and differentiation of human epidermal cells. Oncogene. 2004;23: 1263-1274.
33. Murray AJ. Pharmacological PKA inhibition: all may not be what it seems. Sci Signal. 2008;1: re4.
34. Kress E, Samarut J, Plateroti M. Thyroid hormones and the control of cell proliferation or cell differentiation: paradox or duality? Mol Cell Endocrinol. 2009;313: 36-49.
35. Dentice M, Antonini D, Salvatore D. Type 3 deiodinase and solid tumors: an intriguing pair. Expert Opin Ther Targets. 2013;17: 1369-1379.
36. Yen PM. Physiological and molecular basis of thyroid hormone action. Physiol Rev. 2001;81: 1097-1142.
37. Sun G, Shi YB. Thyroid hormone regulation of adult intestinal stem cell development: mechanisms and evolutionary conservations. Int J Biol Sci. 2012; 8: 1217-1224.
38. Ng L, Lyubarsky A, Nikonov SS, et al. Type 3 deiodinase, a thyroid-hormoneinactivating enzyme, controls survival and maturation of cone photoreceptors. J Neurosci. 30: 3347-3357.
39. Sar P, Peter R, Rath B, Das Mohapatra A, Mishra SK. 3, 35 triiodo L thyronine induces apoptosis in human breast cancer MCF-7 cells, repressing SMP30 expression through negative thyroid response elements. PLoS One. 2011;6: e20861.
40. Chan IH, Privalsky ML. Thyroid hormone receptors mutated in liver cancer function as distorted antimorphs. Oncogene. 2006;25: 3576-3588.
41. Li Z, Meng ZH, Chandrasekaran R, et al. Biallelic inactivation of the thyroid hormone receptor -1 gene in early stage breast cancer. Cancer Res. 2002;62: 1939-1943.
42. Oro AE, Higgins KM, Hu Z, Bonifas JM, Epstein EH Jr, Scott MP. Basal cell carcinomas in mice overexpressing sonic hedgehog. Science. 1997;276: 817-821.
43. Aszterbaum M, Beech J, Epstein EH Jr. Ultraviolet radiation mutagenesis of hedgehog pathway genes in basal cell carcinomas. J Investig Dermatol Symp Proc. 1999;4: 41-45.
44. Bhatia N, Thiyagarajan S, Elcheva I, et al. Gli2 is targeted for ubiquitination and degradation by β-TrCP ubiquitin ligase. J Biol Chem. 2006;281: 19320-19326.
45. Sechman A, Pawlowska K, Hrabia A. Effect of 3, 3, 5-triiodothyronine and 3, 5-diiodothyronine on progesterone production, cAMP synthesis, and mRNA expression of STAR, CYP11A1, and HSD3B genes in granulosa layer of chicken preovulatory follicles. Domest Anim Endocrinol. 2011;41: 137-149.
46. Goldman S, Dirnfeld M, Abramovici H, Kraiem Z. Triiodothyronine (T3) modulates hCG-regulated progesterone secretion, cAMP accumulation and DNA content in cultured human luteinized granulosa cells. Mol Cell Endocrinol. 1993;96: 125-131.
47. DongJ, LiuW, WangY, HouY, Xi Q, Chen J. Developmental iodine deficiency resulting in hypothyroidism reduces hippocampal ERK1/2 and CREB in lactational and adolescent rats. BMC Neurosci. 2009;10: 149.
48. Méndez-PertuzM, Sánchez-Pacheco A, Aranda A. The thyroid hormone receptor antagonizes CREB-mediated transcription. EMBO J. 2003;22: 3102-3112.
49. Pasca di Magliano M, Hebrok M. Hedgehog signalling in cancer formation and maintenance. Nat Rev Cancer. 2003;3: 903-911.
50. Kean S. Medicine. Disrupting Hedgehog may reverse advanced cancer, if only temporarily. Science. 2009;325: 1188.
51. LauthM, Bergström A, ShimokawaT, Toftgård R. Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists. Proc Natl Acad Sci USA. 2007;104: 8455-8460.
52. Lauth M, Toftgård R. Non-canonical activation of GLI transcription factors: implications for targeted anti-cancer therapy. Cell Cycle. 2007;6: 2458-2463.